Julie Rehmeyer's 'Through the Shadowlands'
Writer Never Give Up talks about Julie Rehmeyer's new book "Through the Shadowlands: A Science Writer's Odyssey into an Illness Science Doesn't Understand" and shares an interview with Julie ...
Discuss the article on the Forums.

Scandal in BMJ's XMRV/CFS Research

Discussion in 'Media, Interviews, Blogs, Talks, Events about XMRV' started by parvofighter, Mar 22, 2010.

  1. parvofighter

    parvofighter Senior Member

    BMJ and XMRV Unplugged

    PART 1
    Much has been made of the well-characterized or well-defined patient cohorts (http://www.bmj.com/cgi/content/abstract/340/feb25_1/c1018) of the failed XMRV-in-ME/CFS (Myalgic Encephalomyelitis/Chronic Fatigue Syndrome) replication attempts. Well characterized somberly implies that the patients studied were robustly and meaningfully comparable to those in the landmark Science XMRV study. Namely: Canadian/Fukuda Criteria Chronic Fatigue Syndrome patients with severe disability, reproducible immune abnormalities, cognitive deficits, prolonged, disabling fatigue, low V02 max, and multiple longitudinal measurements of clinical and laboratory abnormalities (http://www.sciencemag.org/cgi/content/full/1179052/DC1 ).

    Well-characterized carries an aura of respectability defying readers to challenge the issue of cohort selection in XMRV research. And it has been abundantly used in the checkered history of Chronic Fatigue Syndrome research. The latest well-characterized XMRV study in Chronic Fatigue Syndrome was ushered into the expectant scientific community by the esteemed British Medical Journal. In her Editors Choice letter (http://www.bmj.com/cgi/content/full...FIRSTINDEX=0&sortspec=date&resourcetype=HWCIT ) accompanying the latest XMRV retroviral study by psychiatrists (Van Kuppeveld et al), Fiona Godlee empathetically waxed poetic on the roller coaster of emotions ME/CFS patients had endured since the BMJs publication of the latest rebuttal of XMRV/CFS research:
    Meanwhile, and sadly for those whose hopes had been raised, the (Science) study has been refuted by three further case-control studies, one of them in the BMJ (doi:10.1136/bmj.c1018).
    With a funereal tone, Godlee cited the somber news that, claims of association between retroviruses and diseases often fail to withstand the test of time (doi:10.1136/bmj.c1099). AIDS patients around the world bowed their heads in silence as the coffin began to close on XMRVs association with ME/CFS.

    Godlee went on to provide a thrilling and compelling rationale for the BMJs publication of the latest XMRV research:
    The paper by Van Kuppeveld and colleagues is an unusual paper for the BMJ to publish. As our research highlights page explains, we would usually reject a small case-control study examining the prevalence of a virus in 20 year old blood samples. Instead we fast tracked it. We did this because its about an important and debilitating syndrome thats often seen by generalists and because we felt it added to an important and highly controversial debate. We and our reviewers also thought it was well done.
    Godlee gamely heralded a new era of scientific excellence for Chronic Fatigue Syndrome and XMRV, entitling her missive with the serious invocation: Lets Proceed with Caution. Godlee wisely enlisted the help of experts: Cathie Sudlow stepped up to the plate to help her navigate the minefields of credible scientific enquiry:
    As an epidemiologist, Cathie Sudlows initial response was skeptical, quickly confirmed when she saw that the paper lacked basic methodological information. "Where were the details of the characteristics and selection procedures for the cases and controls, or of blinding of researchers to the case-control status of the samples? Where was the discussion of the potential role of bias and confounding?".
    Godlee may be handicapped when it comes to irony, and Sudlow, when it comes to reading Sciences Supporting Online Materials (www.sciencemag.org/cgi/content/full/1179052/DC1 ) but they are a force to be reckoned with when it comes to promoting quality scientific research. Godley closed her tome on XMRV and ME/CFS with a flourish:
    So yes, lets have more research into chronic fatigue syndrome,
    but lets make sure its good enough research.

    Despite her evident talents as a BMJ editor, Godlee is subtly handicapped when it comes to her sense of irony. But this doesnt deter her zealous scientific pursuits. Godlees, and indeed the BMJs enthusiasm for quality medical research is iron-clad particularly when it is associated with a retrovirus believed to cause devastating neuro-immune disease and cancer - and this we enthusiastically applaud.

    In Part 2, lets next explore the wonders of Van Kuppeveld et als BMJ XMRV work, and the source of their highly credible patient cohort.
  2. parvofighter

    parvofighter Senior Member

    BMJ Scandal, Part 2

    BMJ and XMRV Unplugged:

    PART 2

    A well-defined patient cohort

    Where did Van Kuppevelds patients come from?
    Enthralled by the British Medical Journals unbiased coverage of XMRV and Chronic Fatigue Syndrome, I began a quest to learn more about these hapless patients. Where did they come from? What did they do to earn the distinction of being a well-defined patient cohort, as described in the BMJ articles Study Design section (http://www.bmj.com/cgi/content/abstract/340/feb25_1/c1018)? After all, the Chronic Fatigue Jihadists those nasty ME/CFS patients were nipping annoyingly at my heels.
    My first stop was the Methods section of Van Kuppeveld et als BMJ masterpiece: Prevalence of xenotropic murine leukaemia virus-related virus in patients with chronic fatigue syndrome in the Netherlands: retrospective analysis of samples from an established cohort. http://www.bmj.com/cgi/content/full/340/feb25_1/c1018
    Methods All patients and controls examined in this study were part of a Dutch cohort of 298 patients, which has been described in detail (2 citations provided below). All patients of this cohort fulfilled the Oxford criteria.
    With grateful credit to the genuinely brilliant Gerwyn on the Phoenix Rising Forums (,http://www.forums.aboutmecfs.org/sh...-in-the-Dutch-XMRV-study.&highlight=vercoulen ), I then turned my attention to the two papers cited as sources for the patients for the BMJ Van Kuppeveld study. These were:

    1. Vercoulen JH, Swanink CM, Fennis JF, Galama JM, van der Meer JW, BleijenbergG. Dimensional assessment of chronic fatigue syndrome. J Psychosom Res 1994;38:383-92. http://dare.ubn.kun.nl/bitstream/2066/14900/1/4783.pdf
    2. Swanink CM, Vercoulen JH, Galama JM, Roos MT, Meyaard L, van der Ven-Jongekrijg J, et al. Lymphocyte subsets, apoptosis, and cytokines in patients with chronic fatigue syndrome. J Infect Dis 1996;173:460-3. http://www.ncbi.nlm.nih.gov/pubmed/8568312
    BMJ XMRV patients sourced from a study in the Journal of Psychosomatic Research!
    I like to know who Im reading about, so I was thrilled to learn on PubMed that J.H. Vercoulen, lead author in the prime study where patients were obtained, had practiced over many years at the Department of Medical Psychology at University Hospital Nijmegen/ Radboud University Nijmegen Medical Center in The Netherlands. I was also pleased to see that of the BMJ XMRV/CFS authors, at least three of them (Swanink, Galama , and van der Meer) had participated in the source studies. What luck!

    This guaranteed that the BMJ XMRV research team would be intimately familiar with
    the patient cohort characteristics they drew from for their CFS study!

    Dispensing with the Swanink Study
    I was able to dispense quickly with the Swanink study (http://www.ncbi.nlm.nih.gov/pubmed/8568312) because all they did in terms of their cohort, was to randomly select them from the Vercoulen study:
    Seventy-six patients and 69 healthy controls matched for sex, age, and neighborhood were included in the study. As described before, patients were randomly chosen from a data base of 298 patients with CFS using a table of random numbers.

    The database of 298 patients used for the XMRV/CFS research: The Vercoulen, Journal of Psychosomatic Research Study!
    Now for the source of these well characterized patients! Given how suspicious the BMJ is about research quality, I thought it wise to include actual screen captures of this cohort description. All excerpts are from: the Vercoulen et. al. article from the Journal of Psychosomatic Research: http://dare.ubn.kun.nl/bitstream/2066/14900/1/4783.pdf Here we go


    Of note was the last sentence: These inclusion and exclusion procedures resulted in a study sample of 298 subjects.

    • 395 self-referred patients
    • Patients with definite or suspected illnesses causing fatigue excluded
    • Patients taking heart meds excluded i.e. many advanced ME/CFS patients excluded
    • Final study sample of 298
    Gerwyn on the PR Forums was audacious enough to question the self-referral and telephone diagnosis process. Surely this was on par with the Science patient cohort procedures!
    Addressing the BMJ and Cathie Sudlows concerns about bias and confounding
    I was gratified that the BMJ XMRV articles patient samples came from a study from the esteemed Journal of Psychosomatic Research. As a peer-reviewed journal, this would ensure that any bias or confounding factors a valid concern explicitly raised by the BMJ would be summarily dealt with. And after all, the British Medical establishment has an illustrious history of cooperating with psychiatrists in the pursuit of a biomedical cause for ME/CFS. Just ask Simon Wesseley. Fortunately, it was clear that CFS patients seen in the Vercoulen source cohort were not treated with any bias. A wonderful example of this is in the discussion on Avoidance behavior a well-known tactic of indolent, exercise-averse ME/CFSers. Despite years of being jocks, it is indeed perplexing that many ME/CFSers characteristically avoid activity like the plague. Almost like a switch went off in their motivation and personality.


    I also enjoyed the Cognitions and Attributions section, where CFSers were asked to mull over the causes of their complaining nature. After all, it is this kind of Cognitive Behavior Therapy-infused atmosphere that causes ME/CFS patients to flock (and self-refer!) to these experts in droves! Theres nothing in a neuro-immune disease, potentially caused by a cancer-causing retrovirus, that a little attitude adjustment cant help.

    Self-reported Symptoms a hallmark of good XMRV cohort design
    There was a slight hiccup in my enthusiasm for the BMJs scientific prowess, when I bumbled over Table 1: Spontaneously reported complaints by 298 CFS-patients. Here was a list of the various ailments of these patients:


    It was a little disturbing that a group that otherwise so perfectly matched the Science cohort with reproducible immune abnormalities, would only have 26% of patients with recurrent infections. And maybe moreso that patients didnt mention or even describe post-exertional malaise, the pathognomic sign for Canadian-Criteria ME/CFS. Then again, the Vercoulen et al work predated the Canadian Criteria. Ah, but thats just one of the pitfalls when youre living in the fast lane with BMJ. Be reasonable world-class scientists researching the next AIDS cant be expected to wait to use the Canadian-Criteria when theyre in a rush and have 16-year old Oxford Criteria blood handy!

    Stand by for Part 3
  3. Adam


    Sheffield UK

    I struggle with irony. My son is always pointing out what is and isn't irony (largely because of the influence of GCSE English teacher).

    No Dad, I don't think that's irony. It's just coincidence.

    Thanks son.

    It's ironical isn't it that journalists working for an esteemed medical journal appear to be doing a disservice to sick people, when surely you would have thought they would wish to 'help' sick people?

    Is that irony son?

    Nice one Parvo :victory:
  4. parvofighter

    parvofighter Senior Member

    Scandal in the BMJ's XMRV research

    BMJ and XMRV Unplugged:

    PART 3

    Power to the people: Self-reported physical findings
    I then reminded myself that all these symptoms were self-reported, and my concerns about scientific integrity at the BMJ were quickly assuaged.
    It was wonderful to see the patients given so much latitude to define their own symptoms! Far simpler too, for them to do this as a take-home questionnaire, and to self-report their medical status, than to submit to all those pesky longitudinal measurements of clinical and laboratory abnormalities that those Yanks used. (http://www.sciencemag.org/cgi/content/full/1179052/DC1 ).

    Psychological well-being
    Things were going really well. Remember the voice of the BMJ Swat Team of reviewers when they evaluated the Van Kuppeveld paper?
    We and our reviewers also thought it was well done.

    Long live the British Medical Journal! I just knew that we could count on a scientifically robust evaluation on XMRV Science from unbiased reviewers like the BMJ and the global media! So it could be considered just a slight indiscretion that the Van Kuppeveld team slipped in a patient cohort where 36% met the criteria for clinical depression. Yes, you heard that right! But dont worry


    Using a score of 16 or more, 36% of patients could be
    considered as having a clinical depression.

    Now first of all, I wanted to check the numbers. The Vercoulen et al paper had 298 patients (after all exclusions were performed); the 2nd source paper by Swanink et al had 76 CFS patients. BUT these Swanink patients were drawn from Vercoulens original 298. And since these were randomly drawn, the same % (36% clinically depressed patients) can be expected to hold.

    I actually checked the front cover of the Vercoulen et al paper to make sure that I wasnt seeing things. But then I realized that I was probably just being paranoid. Or depressed. What was the big deal if 36% of the BMJ XMRV/CFS cohort had clinical depression? There was no reason for me to doubt the medical establishment or even the Chronic Fatigue Immune Dysfunction Association of America who had encouraged patients and the international media to relax about pesky cohort issues. I found myself lulled by the prestige with which the BMJ and its coterie are revered. No cause for alarm. All those stern admonishments to the ME/CFS patient community to stop whining about XMRV methodology and cohort selection were well-founded. This BMJ-feedback-loop really works!

    Patients with Unexplained Fatigue = Patients with ME/CFS
    My education was progressing, and my pulse quickened when I saw in the Discussion that the Vercoulen team were capable of some high-octane self-criticism: the hallmark of any excellent scientist:
    The sample was self-referred. Well, we just learned that. But what I now learned was that this XMRV cohort was generalizable to other patients with Unexplained Fatigue! This was brilliant! After all, every one knows that Unexplained Fatigue is the same as ME/CFS! Even better, there was no qualitative difference in any measure they used (!) between patients with Unexplained Fatigue and the patients (blood) enrolled in the XMRV study except that the XMRV patients were just a tad worse than your run-of-the-mill Unexplained Fatigue patient. We were in good company! This was panning out to be a perfect match with the Science cohort!

    Minimalizing the risk of including patients with delayed convalescence of a viral infection!
    Its a good thing that the BMJ has such a crackerjack team of editors and research consultants! Otherwise I might worry that they missed the part where the Vercoulen team
    Minimalized the risk of including patients with
    delayed convalescence of a viral infection

    Of course, a sharp epidemiologist like the BMJs Cathie would sound off about here:
    Where was the discussion of the potential role of bias and confounding?".
    Its nice that we dont have to hold the BMJ XMRV researchers to the same standards as those US Science louts. I mean, this is the BMJ were talking about. Theres no way that in their desire some 16 years ago to keep out patients with delayed convalescence of a viral infection, the CFS researchers of that age might have - unwittingly of course filtered out by other means too, the patients with any hint of viral etiology. And theres no way that in their desire to preserve mutually beneficial relationships with renowned psychiatrists and insurance companies, the BMJ might forget to shine their own shoes. Im glad that weve got Cathie Sudlow and Fiona Godlee on our team! This is kinda like flying Singapore Airlines. You can just relax, lay back, and let the BMJ experts take care of investigator bias and the 3rd human retrovirus!

    Fatigue severity the principal complaint
    Everybody knows that ME/CFS is just a lot of plain old tiredness, where patients just need a good kick in the butt! So it wasnt surpising that when the hotshot statisticians looked at the Vercoulen et al study, they said the following:
    In other words, the sadder these BMJ patients were (16 years ago), the less they did, and the less they expected they could control their life: the more tired they got. Thats what Vercoulens data proved. That their patients were depressed. Or at least pretty darn lackluster. This sounds like a patient group in need of a motivational speaker! Or CBT. For all you non-statisticians (including me), R2 is just a fancy way of saying, is there a linear relationship? For example, as psychological wellbeing goes down, does the data show us that fatigue severity goes down too? If you have an R2 of 1.0, the answer is YES, WAY! If its zero well, no. The only downside was that the R2 for this argument was kinda wishy-washy at 0.51. And even then, that only explained 27% of the variance.

    Actually, at the end of the day, they found that their research wasnt quite as strong as they hoped:
    Stand by for Part 4
  5. Gerwyn

    Gerwyn Guest

    have a look at the table of dependent and independent variables re causation if you really want a laugh!
  6. parvofighter

    parvofighter Senior Member

    Scandal in BMJ XMRV research - Part 4

    BMJ and XMRV Unplugged:

    PART 4
    The combined effect of related dimensions explained only a
    minor to moderate part of variance.

    In other words, the team was pretty much scratching their heads, although a bit of a trend was becoming evident. Fortunately, if you color-code the various relationships, you can get an idea of what kind of patients these were. First of all, lets take a look at the table that Gerwyn referenced, Table VI from Vercoulen et al.
    Gerwyn's table 2..jpg
    Wikipedia (which has its own dramas on the XMRV/CFS research) gave a nice, quick definition of Dependent and Independent Variable:
    In a statistics experiment, the dependent variable is the event studied and expected to change whenever the independent variable is altered.

    Example: If one were to measure the influence of different quantities of fertilizer on plant growth, the independent variable would be the amount of fertilizer used (the changing factor of the experiment). The dependent variables would be the growth in height and/or mass of the plant

    So in the chart above, theyre saying that the key symptom, Fatigue Severity, is influenced (somewhat) by Psychological wellbeing, Functional Impairment, and Self-Efficacy.

    Is there a way to make all of this make sense, so we can see if the 16-year old blood in the BMJ Van Kuppeveld paper had the same (or at least a VERY similar) cohort to the Science patients? Out of interest, I drew a flow-chart, starting with Fatigue Severity, following the items in Table VI, and working from Fatigue Severity toward the right hand side of the page. I color-coded items that were pretty much psychological in yellow. Items that were mixed physical/psychological I put in yellow/green rainbow. This whole research paper was all subjective, so I was in good company. I was going to put pure physical items in green. But unfortunately I couldnt find any, as in the Science cohort (such as 2-5A Synthetase/RNase-L deficiency or V02 Max abnormalities, or low Natural Killer cell cytotoxicity measures.) So I kept things simple.

    First things first, heres a guide to the abbreviations:

    Yellow = mainly Psychological items
    ψWb= Psychological wellbeing (using the Greek letter psi or ψ)
    SEf = Self-efficacy
    SoF = Social functioning
    CAt = Causal attributions (what do you blame your tiredness on)
    APA = Avoidance of physical activity

    Yellow/green = mixed Psychological/Physical
    FS = Fatigue severity (the main symptom according to them)
    FI = Functional impairment (things you cant do)
    Con = Concentration
    SDi = Sleep disturbances

    No Green (Pure Physical) items
    Like 2-5A Synthetase/RNase-L deficiency
    Or V02 Max abnormalities
    Or low Natural Killer cell cytotoxicity measures
    I ignored the perfection of the regression line (R2 = 0 to 1) and just focused on the percentage of variance explained in these relationships. After all, this was just for illustrative purposes. The bottom line is that if you follow these unspectacular linkages all the way to the right side of the page, a very rough estimate is that 70% of the factors that can be identified to drive Fatigue Severity in the BMJs cohort are psychological, and the remaining 30% are partly psychological. And together, they still only (weakly) explain 28% of the variance. Which rather nicely summarizes the perspectives of many CFS researchers 16 years ago and even today. They don't know what they're studying. Yet this reinforces the British and indeed Dutch paradigm to deny ME/CFS patients physical testing and diagnostics. Why bother when its all psychosomatic?!

    Bottom line, there are no pure green boxes which might capture potential biological drivers of ME/CFS. Or which might give a hint (think RNase-L deficiency) that the cohort is somehow vulnerable to viral infections. The green box is devoid of the kinds of physical findings that the Science cohort was characterized by, and which the term Well Characterized and Well defined imply.

    At this point, I conceded that I was indeed depressed. And sorely disappointed. And like totally surprised that my friends at the BMJ came up lacking. And I realized that the BMJs scientific integrity on the XMRV/ME/CFS research wasnt just unplugged. It was defrocked!

    What do you think?

    Stand by for Part 5 of 5
  7. parvofighter

    parvofighter Senior Member

    BMJ Defrocked

    PART 5 of 5

    The BMJ Defrocked

    • Is it meaningful that the BMJ cohort came from 16-year old blood and a psychological paradigm, infused with self-referred CBT enthusiasts, self-completed questionnaires, no clinically measured physical signs, and (at least) 36% clinically depressed patients?

    • Does investigating CFS patients for avoidance behavior, cognitions, and attributions for a publication in the Journal of Psychosomatic Research, in research led by a psychologist, presuppose or create investigator bias toward a psychosomatic illness?

    • How fervent were these researchers in their stated aim to Minimalize the risk of including patients with delayed convalescence of a viral infection?

    • Given this explicit aim of the researchers, what evidence is there that investigator bias was eliminated?

    • Just how zealous were these researchers in excluding patients with signs/symptoms of viral infection?

    • Would a sane patient with reproducible immune abnormalities and severe, disabling fatigue willingly volunteer for a Cognitive Behavior Therapy program or study to eliminate their Abnormal Sickness Beliefs?

    • Would a sane patient with classic Canadian-Criteria ME/CFS, post-exertional malaise, and severe disabling fatigue even consider a Graded Exercise Therapy program?

    • Is Unexplained Fatigue the same as ME/CFS?

    • Has investigator bias been addressed in the Vercoulen paper the source of the archaic blood for the BMJ study? Has bias been addressed in ANY of the BMJ missives on ME/CFS and XMRV?

    • Are the Science and BMJ XMRV cohorts even faintly comparable?

    • Is the BMJs work on XMRV and ME/CFS worth the paper its written on... Or worth the energy to power the pixels on your screen?
    You tell me.


    Wind back to Dr Vernon's statements on the BMJ XMRV study, on behalf of the Chronic Fatigue Immune Dysfunction Association of America:

    XMRV was not detected in a third follow-up study (BMJ) from a
    well-characterized cohortof CFS subjects.

    The PLoS ONE paper by Erlwein, et al, the Retrovirology paper by Groom, et al, and now the van Kuppeveld, et al, paper in BMJ all studied well-characterized patient cohorts that met accepted and widely used CFS case definition criteria.


    BMJ Editor Fiona Godlee was right about one thing:

    So yes, lets have more research into chronic fatigue syndrome,
    but lets make sure its good enough research.

    YES- feel free to post this elsewhere. Kindly give
    credit to the source (just input the link below)
  8. _Kim_

    _Kim_ Guest

    Can someone post this Parvo brilliance (all 5 parts) to Co-Cure? I'm in awe.
  9. parvofighter

    parvofighter Senior Member

    Large version of flow chart in Part 4

    I think I've figured out how to do this. Let me know if you can't read it.

    Here's the file showing the very psychological drivers deduced by the Vercoulen et al team. As Gerwyn noted, good for a laugh.
    View attachment What drives fati&#103.pdf
  10. hvs

    hvs Senior Member

    Holy $%^&, so people taking drugs for low blood pressure or any of the other manifestations of this disease would be excluded??
  11. Gerwyn

    Gerwyn Guest

    kim that is a darn fine idea
  12. vdt33


    Parvo, does this apply to all the other BMJ studies on XMRV or just the Vercoulen team?
  13. Kati

    Kati Patient in training


    What Kim said. Well done Parvo.
  14. Dorothy


    Wonderful information!

    Thanks very much to Parvo for this super-well-done report! It's downright awesome and a treasure trove of information. I would second the motion for posting this on co-cure and other places as well. I now need to go practice some more "avoidance behavior" on the sofa and rest my brain. :Retro smile:
  15. MEKoan

    MEKoan Senior Member

    OMG, Parvo! This is a beautiful thing! This should be posted everywhere including on your very own blog - to which we will all immediately subscribe!

    What a work!

    I'm with Kim - in awe!
  16. leelaplay

    leelaplay member

    Brilliant parvo.

    A agree that scientists and the medical world need to seee this.

    I do think that this needs to get out to at least:

    a) the BMJ

    b) co-cure

    c) make this an article on the forum and have Cort put it on the home page + mail it out to everyone on his list

    d) are there any respected medical journals that would publish?

    and maybe:

    a) WPI's facebook page

    b) the CAA facebook page and/or newsletter

    c) the Prohealth newsletter

    Parvo - are you up to getting this out to all these places? Do you need help? With your permission, I'm sure people would chime in and we'd find people who could get this out. Please let us know what you think.
  17. Gerwyn

    Gerwyn Guest

    i have already done the bmj bit on the issues
  18. Gerwyn

    Gerwyn Guest

    yes parvo that is the key point i originally made according to the authors themselves the origin of the patients symptoms were partly or wholly psychological Wesslyian CFS made in Oxford over lunch
  19. parvofighter

    parvofighter Senior Member

    Thank you - can I punt for now...?

    Thank you all for your uplilfting feedback. I gotta admit I'm WIPED after writing that stuff, and need to crash into bed pronto. Can I punt for now all the follow-up stuff? I did email the WPI with a heads-up, and am really pleased if this info can help us get any traction ANYWHERE! One other quick addition: and I can't believe that I missed it:

    "On the BDI, 32% of patients did not have depressed feelings at all."
    If I interpret that correctly, they are referring to the Beck Depression Inventory.
    SO.... if 32% of patients SAID they didn't have depressed feelings... that would mean that 68% of patients said they DID have depressed feelings... which makes this cohort EVEN worse (as if that were possible), no?
    Any psychologists here know how common it is for "normal" people to register positives on the Beck Depression Inventory? I wonder if our advocates could fight for better availability of data on this cohort too?

    In case you missed it, Gerwyn did a masterful exposee of the Dutch Cohort on this thread: http://www.forums.aboutmecfs.org/sh...-in-the-Dutch-XMRV-study.&highlight=vercoulen . And it was based on his trailblazing that I decided to look again at the whole BMJ issue. I urge you to read Gerwyn's original piece - it's characteristically excellent.

    As for a dreaded summary... as you've all probably guessed, my absolute worst weakness (other than digging) is making summaries. I CAN do it... but it'll take time until I can catch my breath, and come at it fresh again. Will be back as soon as I can...

    Cheers, Parvo:Retro smile:
  20. julius

    julius Watchoo lookin' at?

    Of all the writing I've seen on this whole debacle, this is the Platinum Edition. Brilliant!

    But there's one point I'm confused about, and I think it's just brain fog but if someone could set me straight I appreciate it.

    My question is about this point; the attempt to Minimalize the risk of including patients with delayed convalescence of a viral infection.

    To do this they required that the symptoms be present for at least a year. So wouldn't that be good, in that it would allow for chronic viral infection (herpes, EBV, XMRV) , but rule out a transient viral infection (flu, cold)?

    Like I said, I'm sure I'm just fogged out on this.

See more popular forum discussions.

Share This Page